Jazz Pharmaceuticals plc — Director's Dealing 2025

Dec 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2025-12-05

Reporting Person: GALA RENEE D (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-05	Ordinary Shares	F	80	$166.91	Disposed	107860	Direct

Footnotes

F1: The Reporting Person acquired 71 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.